Applied Genetic Technologies
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Applied Genetic Technologies's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 35% to $325,000. Profit margin reached -21977%. Total operating expenses were $66,500,000.

Profit Margin

Applied Genetic Technologies Corporation (NASDAQ:AGTC): Profit margin
2013 942K -4.99M -529.72%
2014 1.12M -15.90M -1409.03%
2015 2.35M -24.31M -1033.05%
2016 47.36M -1.38M -2.92%
2017 39.47M 407K 1.03%
2018 24.18M -21.3M -88.07%
2019 41.69M -2.00M -4.81%
2020 2.45M -45.89M -1870.85%
2021 500K -57.82M -11565.8%
2022 325K -71.42M -21976.62%

AGTC Income Statement (2013 – 2022)

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013
Revenue
Revenue
325K500K2.45M41.69M24.18M39.47M47.36M2.35M1.12M942K
Cost of revenue
0000000000
Gross profit
325K500K2.45M41.69M24.18M39.47M47.36M2.35M1.12M942K
Operating exp.
Research and development
49.51M44.4M35.77M33.18M32.18M26.21M38.86M16.52M8.50M3.13M
Selling and marketing
0000000000
Total operating expenses
66.5M58.95M49.39M46.04M46.57M37.57M49.45M26.88M13.68M4.53M
Operating income
-66.26M-58.45M-46.94M-4.35M-22.38M1.90M-2.08M-24.53M-12.55M-3.59M
Other income (expenses), net
-2.48M-1.39M1.18M2.45M1.17M905K708K214K-3.35M-1.39M
Income before tax
-68.75M-59.84M-45.76M-1.89M-21.20M2.80M-1.38M-24.31M-15.90M-4.99M
Income tax expense
2.67M-2.10M83K76K72K2.4M708K214K-3.35M-1.20M
Net income
-71.42M-57.82M-45.89M-2.00M-21.3M407K-1.38M-24.31M-15.90M-4.99M
Earnings per share
Basic EPS
-1.59-1.77-2.17-0.11-1.180.02-0.07-1.5-4.46-1.2
Diluted EPS
-1.59-1.77-2.17-0.11-1.180.02-0.07-1.5-4.46-1.2
Data sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData source